The technology for hydrogen production is developed indigenously by BHEL and has high local material content…reports Asian Lite News
The Bhabha Atomic Research Centre (BARC) is set to build an isotope production reactor exclusively for medical purposes, its director Vivek Bhasin has said.
Speaking at the launch of AKTOCYTE, a food supplement for cancer patients, Bhasin also said that the BARC and Tata Memorial Centre hospitals will be providing guidance for setting up nuclear medicine departments in all the medical colleges in the country over the next 20 years, news agency PTI reported.
“The BARC is going to build a new reactor…an isotope production reactor dedicated only for medical isotopes,” he said.
The volume of production will be so high that India will not need to import these isotopes, Bhasin added.
“This will be a novel type of reactor and its design is more or less complete. The project will start soon,” he said.
Last month, Bharat Heavy Electricals Limited (BHEL) had signed an agreement with the Bhabha Atomic Research Centre for 50 kW alkaline electrolyser system to produce hydrogen.
“Bharat Heavy Electricals Limited (BHEL) has entered into a Technology Transfer Agreement (TTA) with Bhabha Atomic Research Centre (BARC) for 50 kW alkaline electrolyser system for Hydrogen production” said BHEL.
The technology for hydrogen production is developed indigenously by BHEL and has high local material content.
BHEL through this collaboration with BARC intends to scale up Indigenous Alkaline Electrolyser Technology and commercialise it for application in sectors such as refineries, fertiliser, steel, transportation, etc.
By leveraging indigenous technology, BHEL aims to contribute significantly for the development of sustainable hydrogen production methods, supporting India’s transition towards cleaner energy sources.
The collaboration between BHEL and BARC represents a crucial step in advancing hydrogen technology and promoting a greener future for the country.
Earlier, BHEL was honoured by POWERGRID at the CEO Meet 2024 for its remarkable achievement in commissioning three critical substations under the Neemuch REZ TBCB project ahead of the contractual schedule, despite facing initial challenges.
The projects aimed at evacuating renewable energy generated by RUMS (Rewa Ultra Mega Solar) under the Neemuch Renewable Energy Zone (REZ) comprised three substations: 400/220 kV Neemuch (New), an extension of 400 kV Chittorgarh, and an extension of 400 kV Mandsaur.
The shares of BHEL have also joined the other PSU’s in the recent rally at the stock market, the company’s shares have surged more than 89 per cent in the last 6 months and on Tuesday’s trading session, stands at Rs 294 at the time of filing this report.
ALSO READ: Kerala Mourns 13 Victims of Kuwait Fire
